Health Services Usage in Patients Receiving Buprenorphine for Opioid Use Disorder or Long-Term Opioid Therapy for Chronic Pain: Retrospective Cohort Study
These findings highlight the value of telemedicine to maintain access among people at risk for poor outcomes if care is interrupted. While flexibilities in the regulation of telemedicine services that arose during the pandemic have been temporarily extended multiple times, they are set to expire in 2025 without further action. Making these changes to telemedicine regulation permanent may benefit vulnerable patient populations who face access to care challenges.
Authors
- Samuel T. Savitz (ORCID: https://orcid.org/0000-0003-3190-7740)
- Gail D’Onofrio (ORCID: https://orcid.org/0000-0002-3833-1871)
- Molly M. Jeffery (ORCID: https://orcid.org/0000-0003-3854-6810)
- Bidisha Nath (ORCID: https://orcid.org/0000-0002-8385-3417)
- Edward R. Melnick (ORCID: https://orcid.org/0000-0002-6509-9537)
- Maria A Stevens (ORCID: https://orcid.org/0000-0003-3184-5834)
Institutions
- Yale University (US)
- Mayo Clinic in Arizona (US)
Publication Details
- Journal
- JMIR Formative Research
- Published
- 2025-06-19
- DOI
- https://doi.org/10.2196/66596
- Primary Topic
- Opioid Use Disorder Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00